Abstract
Mucosal melanoma is a rare subtype of malignant melanoma with a particularly poor prognosis. The neoplasm may be found in all mucosal membranes and the origin of the disease remains largely unknown. Mucosal melanomas are primarily found in the conjunctiva, the sinonasal cavity, the distal gastrointestinal canal, and the female genitals. Slightly more women are affected and the disease mainly develops after the sixth decade of life. Conjunctival melanoma may arise in a nevus or as a premalignant melanocytic lesion, but most mucosal melanomas are considered to have a de novo origin. Genetic alterations in the KIT gene have frequently been found, while BRAF and NRAS mutations are relatively rare. Symptoms relate to the affected organ system and a thorough diagnostic program has to be performed in order to exclude metastatic disease when a mucosal melanoma is diagnosed. Surgery is the mainstay of initial treatment, with other forms of adjuvant therapy, such as radiotherapy, considered as part of a multidisciplinary approach to treatment. Particle radiotherapy has shown some effect, and novel targeted therapies such as the PD-1 inhibitors providing renewed enthusiasm for the treatment of patients with mucosal melanoma. A proper staging system remains undefined, and the development of this would aid future management. Large-scale studies are greatly needed, and clinicians are encouraged to include mucosal melanoma patients in clinical trials regarding novel therapies.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma. Cancer. 1998;85:1664–78.
Lourenco S, Fernandes J, Hsieh R, Coutinho-Camillo CM, Bologna S, Sangueza M, et al. Head and neck mucosal melanoma: a review. Am J Dermatopathol. 2014;36(7):578–87.
Mikkelsen LH, Larsen AC, Buchwald CV, Drzewiecki KT, Prause JU, Heegaard S. Mucosal malignant melanoma—a clinical, oncological, pathological and genetic survey. APMIS. 2016;124(6):475–86.
Carvajal RD, Spencer S, Lydiatt W. Mucosal melanoma: a clinically and biologically unique disease entity. J Natl Compr Cancer Netw. 2012;10(3):345–56.
Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol. 2012;5(8):739–53.
Spencer KR, Mehnert JM. Mucosal melanoma: epidemiology, biology and treatment. Cancer Treat Res. 2016;167:295–320.
Piura B. Management of primary melanoma of the female urogenital tract. Lancet Oncol. 2008;9:973–81.
Seregard S. Conjunctival melanoma. Surv Ophthalmol. 1998;42(4):321–50.
Gavriel H, McArthur G, Sizeland A. Review: mucosal melanoma of the head and neck. Melanoma Res. 2011;21(4):257–66.
Larsen AC, Dahl C, Dahmcke CM, Lade-Keller J, Siersma VD, Toft PB, et al. BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions. Acta Ophthalmol. 2016;94(5):463–70.
Lawaetz M, Birch-Johansen F, Friis S, Eriksen JG, Kiss K, Gade S, et al. Primary mucosal melanoma of the head and neck in Denmark, 1982–2012: Demographic and clinical aspects. A retrospective DAHANCA study. Acta Oncol (Stockholm, Sweden). 2016;55(8):1001–8.
McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103:1000–7.
Jangard M, Hansson J, Ragnarsson-Olding B. Primary sinonasal malignant melanoma: a nationwide study of the Swedish population, 1960–2000. Rhinology. 2013;51(1):22–30.
Larsen AC, Dahmcke CM, Dahl C, Siersma VD, Toft PB, Coupland SE, et al. Conjunctival melanoma: a retrospective review of presentation, treatment and outcome and investigation of features associated with BRAF mutations. JAMA Ophthalmol. 2015;133(11):1295–303.
Isager P, Østerlind A, Engholm G, Lindegaard J, Heegaard S, Overgaard J, et al. Uveal and conjunctival malignant melanoma in Denmark, 1943–97: incidence and validation study. Ophthalmic Epidemiol. 2005;12:223–32.
Triay E, Bergman L, Nilsson B, All-Eircsson C, Seregard S. Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol. 2009;93:1524–8.
Tuomaala S, Eskelin S, Tarkkanen A, Kivelä T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci. 2002;43:3399–408.
Callahan A, Anderson WF, Patel S, Barnholtz-Sloan JS, Bordeaux JS, Tucker MA, et al. Epidemiology of anorectal melanoma in the United States: 1992 to 2011. Dermatol Surg. 2016;42(1):94–9.
Terada T, Saeki N, Toh K, Uwa N, Sagawa K, Mouri T, et al. Primary malignant melanoma of the larynx: a case report and literature review. Auris Nasus Larynx. 2007;34:105–10.
Hicks MJ, Flaitz CM. Oral mucosal melanoma: epidemiology and pathobiology. Oral Oncol. 2000;36:152–69.
Sabanathan S, Eng J, Pradhan GN. Primary malignant melanoma of the esophagus. Am J Gastroenterol. 1989;84:1475–81.
Iddings DM, Fleisig AJ, Chen SL, Faries MB, Morton DL. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol. 2010;17:40–4.
Oliva E, Quinn TR, Amin MB, Eble JN, Epstein JI, Srigley JR, et al. Primary malignant melanoma of the urethra: a clinicopathologic analysis of 15 cases. Am J Surg Pathol. 2000;24(6):785–96.
Falch C, Mueller S, Kirschniak A, Braun M, Koenigsrainer A, Klumpp B. Anorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT. World J Surg Oncol. 2016;14(1):185.
Neugut AI, Kizelnik-Freilich S, Ackerman C. Black-White differences in risk for cutaneous, ocular, and visceral melanomas. Am J Public Health. 1994;84(11):1828–9.
Lazarev S, Gupta V, Hu K, Harrison LB, Bakst R. Mucosal melanoma of the head and neck: a systematic review of the literature. Int J Radiat Oncol Biol Phys. 2014;90(5):1108–18.
Sheng X, Li S, Chi Z, Si L, Cui C, Mao L, et al. Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients. Br J Ophthalmol. 2015;99(25):990–6.
Leitao MM Jr. Management of vulvar and vaginal melanomas: current and future strategies. Am Soc Clin Oncol Educ Book. 2014;2014:e277–81.
Agarwalla PK, Koch MJ, Mordes DA, Codd PJ, Coumans JV. Pigmented lesions of the nervous system and the neural crest: Lessons from embryology. Neurosurgery. 2015;78(1):142–54.
Saida T, Kawachi S, Takata M, Kurita H, Kurashina K, Kageshita T, et al. Histopathological characteristics of malignant melanoma affecting mucous membranes : a unifying concept of histogenesis. Pathology. 2004;36(5):404–13.
Righi A, Dimosthenous K. Primary malignant melanoma of the rectum arisinf against a background of rectal melanosis. Int J Surg Pathol. 2008;16(3):335–6.
Guzman RP, Wightman R, Ravinsky E, Unruh HW. Primary malignant melanoma of the eosophagus with diffuse melanocytic atypia and melanoma in situ. Am J Clin Pathol. 1984;92:802–4.
Meleti M, Mooi WJ, Casparie MK, van der Waal I. Melanocytic nevi of the oral mucosa—no evidence of increased risk for oral malignant melanoma; An analysis of 119 cases. Oral Oncol. 2007;43:976–81.
Missotten GS, Keijser S, De Keizer RJ, De Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci. 2005;46:75–82.
Shields CL, Markowitz JS, Belinsky I, Schwartzstein H, George NS, Lally SE. Conjunctival melanoma: outcomes based on tumour origin in 382 consecutive cases. Ophthalmology. 2011;118(2):389–95.
Ragnarsson-Olding BK, Kanter-Lewensohn LR, Lagerlöf B, Nilsson BR, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females clinical observations and histopathologic features. Cancer. 1999;86(7):1273–84.
Mochel MC, Duncan LM, Piris A, Kraft S. Primary mucosal melanoma of the sinonasal tract: a clinicopathologic and immunohistochemical study of thirty-two cases. Head Neck Pathol. 2015;9(2):236–43.
Sedassari BT, Lascane NA, de Freitas AL, Mautoni MC, Sotto MN, Gallottini MH, et al. In situ melanoma of the gingiva associated with dense inflammation and pigment deposition: a potential diagnostic pitfall in evaluating stromal invasion. Head Neck Pathol. 2016;10(4):547–51.
Jacobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology. 1989;96(2):147–66.
Shields CL, Shields JA, Gündüz K, Cater J, Mercado GV, Gross N, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000;118:1497–507.
Damato B, Coupland S. Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Exp Ophthalmol. 2008;36:786–95.
Holmstrom M, Lund VJ. Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde. Br J Ind Med. 1991;48(1):9–11.
Zhu W, Zou B, Wang S. Clinicopathological features and prognosis of sinonasal mucosal malignant melanoma: a retrospective study of 83 cases in a chinese population. ORL J Otorhinolaryngol Relat Spec. 2016;78(2):94–104.
Rivolta C, Royer-Bertrand B, Rimoldi D, Schalenbourg A, Zografos L, Leyvraz S, et al. UV light signature in conjunctival melanoma; not only skin should be protected from solar radiation. J Hum Genet. 2015;61(4):361–2.
Zhang T, Dutton-Regester K, Brown KM, Hayward NK. The genomic landscape of cutaneous melanoma. Pigment Cell Melanoma Res. 2016;29(3):266–83.
Furney SJ, Turajlic S, Stamp G, Nohadani M, Carlisle A, Thomas JM, et al. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol. 2013;230(3):261–9.
Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature. 2012;485(7399):502–6.
Si L, Wang X, Guo J. Genotyping of mucosal melanoma. Chin Clin Oncol. 2014;3(3):34.
Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135–47.
Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003;163(5):1765–70.
Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. The genome and epigenome of malignant melanoma. Acta Pathol Microbiol Immunol Scand. 2007;115(10):1161–76.
Spendlove HE, Damato BE, Humphreys J, Barker KT, Hiscott PS, Houlston RS. BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res. 2004;14(6):449–52.
Lake SL, Jmor F, Dopierala J, Taktak AG, Coupland SE, Damato BE. Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes. Invest Ophthalmol Vis Sci. 2011;52(8):5598–604.
Zebary A, Jangard M, Omholt K, Ragnarsson-Olding B, Hansson J. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases. Br J Cancer. 2013;109(3):559–64.
Omholt K, Grafström E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res. 2011;17(12):3933–42.
Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res. 2008;14(21):6821–8.
Curtin J, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24(26):4340–6.
Santi R, Simi L, Fucci R, Paglierani M, Pepi M, Pinzani P, et al. KIT genetic alterations in anorectal melanomas. J Clin Pathol. 2015;68(2):130–40.
Turri-Zanoni M, Medicina D, Lambardi D, Ungari M, Balzarini P, Rossini C, et al. Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck. 2013;35(8):1066–77.
Hsieh R, Nico MS, Coutinho-camillo CM, Buim ME, Sangueza M, Lourenço SV. The CDKN2A and MAP kinase pathways: molecular roads to primary oral mucosal melanoma. Am J Dermathol Pathol. 2013;35(2):167–75.
Sheng X, Kong Y, Li Y, Zhang Q, Si L, Cui C, et al. GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis. Eur J Cancer. 2016;65:156–63.
Jangard M, Zebary A, Ragnarsson-Olding B, Hansson J. TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases. Melanoma Res. 2015;25(3):185–8.
Larsen AC, Mikkelsen LH, Borup R, Kiss K, Toft PB, Von Buchwald C, et al. MicroRNA expression profile in conjunctival melanoma. Invest Opthalmol Vis Sci. 2016;57(10):4205.
Jacobiec FA, Bhat P, Colby KA. Immunohistochemical studies of conjunctival nevi and melanomas. Arch Ophthalmol. 2010;128(2):174–83.
Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol. 2003;27:594–611.
Volpin E, Sauvanet A, Couvelard A, Belghiti J. Primary malignant melanoma of the esophagus: a case report and review of the literature. Dis Esophagus. 2002;15:244–9.
Cheung MC, Perez EA, Molina MA, Jin X, Gutierrez JC, Franceschi D, et al. Defining the role of surgery for primary gastrointestinal tract melanoma. J Gastrointest Surg. 2008;12:731–8.
Pacella M, Gallo F, Gastaldi C, Ambruosi C, Carmignani G. Primary malignant melanoma of the bladder. Int J Urol. 2006;13:635–7.
Grozinger G, Mann S, Mehra T, Klumpp B, Grosse U, Nikolaou K, et al. Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study. Eur Radiol. 2016;26(6):1826–34.
Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck. 2002;24:247–57.
O’Regan K, Breen M, Ramaiya N, Jagannathan J, DiPiro PJ, Hodi FS, et al. Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence. Cancer Imaging. 2013;13(4):626–32.
Birch-Johansen F, Buchwald CV, Drzewiecki KT. Slimhinde melanomer i hoved-halsregionen [In Danish] Copenhagen2013. www.melanoma.dk
Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, et al. Mucosal melanoma of the head and neck. J Natl Compr Cancer Netw. 2012;10(3):320–38.
Surabhi VR, Menias CO, Amer AM, Elshikh M, Katabathina VS, Hara AK, et al. Tumors and tumorlike conditions of the anal canal and perianal region: MR imaging findings. Radiographics. 2016;36(5):1339–53.
Ferraioli D, Lamblin G, Mathevet P, Hetu J, Berakdar I, Beurrier F, et al. Genital melanoma: prognosis factors and treatment modality. Arch Gynecol Obstet. 2016;294(5):1037–45.
Schaefer T, Satzger I, Gutzmer R. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: a retrospective analysis of 75 patients. Medicine. 2017;96(1):e5753.
AJCC Cancer Staging Manual. 8th ed. Springer International Publishing; 2016.
Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ. Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors. Cancer. 2004;100(8):1657–64.
Ballantyne AJ. Malignant melanoma of the skin of the head and neck. An analysis of 405 cases. Am J Surg. 1970;120(4):425–31.
Shah J, Huvos A, Strong E. Mucosal melanomas of the head and neck. Am J Surg. 1977;134:531–5.
Chung AF, Woodruff JM, Lewis JL Jr. Malignant melanoma of the vulva: a report of 44 cases. Obstet Gynecol. 1975;45(6):638–46.
Gal TJ, Silver N, Huang B. Demographics and treatment trends in sinonasal mucosal melanoma. Laryngoscope. 2011;121(9):2026–33.
Meleti M, Leemans CR, Mooi WJ, Vescovi P, van der Waal I. Oral malignant melanoma: a review of the literature. Oral Oncol. 2007;43(2):116–21.
Chae WY, Lee JL, Cho DH, Yu CS, Roh J, Kim JC. Preliminary suggestion about staging of anorectal malignant melanoma may be used to predict prognosis. Cancer Res Treat. 2016;48(1):240–9.
Seifried S, Haydu LE, Quinn MJ, Scolyer RA, Stretch JR, Thompson JF. Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases. Ann Surg Oncol. 2015;22(6):1959–66.
Damato B, Coupland S. Ocular melanoma. Saudi J Ophthalmol. 2012;26(2):137–44.
Damato B, Coupland SE. Management of conjunctival melanoma. Expert Rev Anticancer Ther. 2009;9(9):1227–39.
Norregaard JC, Gerner N, Jensen OA, Prause JU. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1996;234(9):569–72.
Pfeiffer ML, Ozgur OK, Myers JN, Peng A, Ning J, Zafereo ME, et al. Sentinel lymph node biopsy for ocular adnexal melanoma. Acta Ophthalmol. 2017;95(4):e323–8.
Mendoza PR, Grossniklaus HE. Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence? Int Ophthalmol Clin. 2015;55(1):123–36.
Lombardi D, Bottazzoli M, Turri-Zanoni M, Raffetti E, Villaret AB, Morassi ML, et al. Sinonasal mucosal melanoma: a 12-year experience of 58 cases. Head Neck. 2016;38(Suppl 1):E1737–45.
Won TB, Choi KY, Rhee CS, Jin HR, Yi JS, Dhong HJ, et al. Treatment outcomes of sinonasal malignant melanoma: a Korean multicenter study. Int Forum Allergy Rhinol. 2015;5(10):950–9.
Bello DM, Smyth E, Perez D, Khan S, Temple LK, Ariyan CE, et al. Anal versus rectal melanoma: does site of origin predict outcome? Dis Colon Rectum. 2013;56(2):150–7.
Nilsson PJ, Ragnarsson-Olding BK. Importance of clear resection margins in anorectal malignant melanoma. Br J Surg. 2010;97(1):98–103.
Han J, Shi C, Dong X, Wang J, Wen H, Wang B, et al. Laparoscopic abdomino-perineal resection for patients with anorectal malignant melanoma: a report of 4 cases. J Biomed Res. 2016;30(5):436–40.
Iacoponi S, Rubio P, Garcia E, Oehler MK, Diez J, Diaz-De la Noval B, et al. Prognostic factors of recurrence and survival in vulvar melanoma: subgroup analysis of the VULvar CANcer study. Int J Gynecol Cancer. 2016;26(7):1307–12.
Ragnarsson-Olding BK. Primary malignant melanoma of the vulva an aggressive tumor for modeling the genesis of non-UV light-associated melanomas. Acta Oncol. 2004;43(5):421–35.
Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, et al. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010;116(6):1358–65.
Todo Y, Okamoto K, Suzuki Y, Minobe S, Kato H. Radicality of initial surgery for primary malignant melanoma of the vagina. Melanoma Res. 2016;26(2):173–80.
Lee JH, Yun J, Seo JW, Bae GE, Lee JW, Kim SW. Primary malignant melanoma of cervix and vagina. Obstet Gynecol Sci. 2016;59(5):415–20.
Leitao MM, Cheng X, Hamilton AL, Siddiqui NA, Jurgenliemk-Schulz I, Mahner S, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas. Int J Gynecol Cancer. 2014;24(9):117–22.
Gao S, Li J, Feng X, Shi S, He J. Characteristics and surgical outcomes for primary malignant melanoma of the esophagus. Sci Rep. 2016;6:23804.
Ost D, Joseph C, Sogoloff H, Menezes G. Primary pulmonary melanoma: case report and literature review. Mayo Clin Proc. 1999;74:62–6.
Khalid U, Saleem T, Imam AM, Khan MR. Pathogenesis, diagnosis and management of primary melanoma of the colon. World J Surg Oncol. 2011;9:14.
Papes D, Altarac S, Arslani N, Rajkovic Z, Antabak A, Cacic M. Melanoma of the glans penis and urethra. Urology. 2014;83(1):6–11.
Smith NE, Taube JM, Warczynski TM, Collier KD, Pawlik TM. Primary biliary tract melanoma: report of a case and review of the literature. Int J Surg Case Rep. 2012;3:441–4.
Pittaka M, Kardamakis D, Spyropoulou D. Comparison of international guidelines on mucosal melanoma of the head and neck: a comprehensive review of the role of radiation therapy. In vivo (Athens, Greece). 2016;30(3):165–70.
Cantuaria G, Angioli R, Nahmias J, Estape R, Penalver M. Primary malignant melanoma of the uterine cervix: case report and review of the literature. Gynecol Oncol. 1999;75:170–4.
Kelly P, Zagars GK, Cormier JN, Ross MI, Guadagnolo BA. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience. Cancer. 2011;117(20):4747–55.
Kirschner AN, Kidd EA, Dewees T, Perkins SM. Treatment approach and outcomes of vaginal melanoma. Int J Gynecol Cancer. 2013;23(8):1484–9.
Damato B, Coupland SE. An audit of conjunctival melanoma treatment in Liverpool. Eye (Lond). 2009;23(4):801–9.
Fuji H, Yoshikawa S, Kasami M, Murayama S, Onitsuka T, Kashiwagi H, et al. High-dose proton beam therapy for sinonasal mucosal malignant melanoma. Radiat Oncol (London, England). 2014;9:162.
Zenda S, Akimoto T, Mizumoto M, Hayashi R, Arahira S, Okumura T, et al. Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses. Radiother Oncol. 2016;118(2):267–71.
Liao JJ, Parvathaneni U, Laramore GE, Thompson JA, Bhatia S, Futran ND, et al. Fast neutron radiotherapy for primary mucosal melanomas of the head and neck. Head Neck. 2014;36(8):1162–7.
Yanagi T, Mizoe JE, Hasegawa A, Takagi R, Bessho H, Onda T, et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys. 2009;74(1):15–20.
Naganawa K, Koto M, Takagi R, Hasegawa A, Ikawa H, Shimozato K, et al. Long-term outcomes after carbon-ion radiotherapy for oral mucosal malignant melanoma. J Radiat Res. 2017;58(4):517–22.
Karasawa K, Wakatsuki M, Kato S, Kiyohara H, Kamada T. Clinical trial of carbon ion radiotherapy for gynecological melanoma. J Radiat Res. 2014;55(2):343–50.
Ozyigit G, Cengiz M, Yazici G, Yildiz F, Sezen D, Yildiz D, et al. Robotic stereotactic body radiotherapy in the treatment of sinonasal mucosal melanoma: report of four cases. Head Neck. 2013;35(3):E69–73.
Lian B, Si L, Cui C, Chi Z, Sheng X, Mao L, et al. Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma. Clin Cancer Res. 2013;19(16):4488–98.
Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman RA, Teitcher J, et al. KIT as a therapeutic target in metastatic melanoma. JAMA. 2011;305(22):2327–34.
Hodi FS, Corless CL, Giobbie-Hurder A, Fletcher JA, Zhu M, Marino-Enriquez A, et al. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol. 2013;31(26):3182–90.
Larkin J, Ascierto PA, Dreno B, Atkinson V, Liszkay G, Maio M, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med. 2014;371(20):1867–76.
Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, et al. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med. 2014;371(20):1877–88.
Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med. 2015;372(1):30–9.
Del Vecchio M, Di Guardo L, Ascierto PA, Grimaldi AM, Sileni VC, Pigozzo J, et al. Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma. Eur J Cancer. 2014;50(1):121–7.
Thierauf J, Veit JA, Lennerz JK, Weissinger SE, Affolter A, Doscher J, et al. Expression of Kallikrein-related peptidase 6 in primary mucosal malignant melanoma of the head and neck. Head Neck Pathol. 2017;11(3):314–20.
D’Angelo SP, Larkin J, Sosman JA, Lebbe C, Brady B, Neyns B, et al. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol. 2017;35(2):226–35.
Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med. 2015;372(26):2521–32.
Shoushtari AN, Munhoz RR, Kuk D, Ott PA, Johnson DB, Tsai KK, et al. The efficacy of anti-PD-1 agents in acral and mucosal melanoma. Cancer. 2016;122(21):3354–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Mikkelsen, L.H., Heegaard, S. (2018). Mucosal Melanoma. In: Riker, A. (eds) Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-319-78310-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-78310-9_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78309-3
Online ISBN: 978-3-319-78310-9
eBook Packages: MedicineMedicine (R0)